Advertisement

 

 

Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.

Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.
Author Information (click to view)

Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, Mugyenyi P, Domingo P, Hoffmann C, Read TR, Pujari S, Meulbroek M, Johnson M, Wilkin T, Mitsuyasu R, ,


Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, Mugyenyi P, Domingo P, Hoffmann C, Read TR, Pujari S, Meulbroek M, Johnson M, Wilkin T, Mitsuyasu R, , (click to view)

Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, Mugyenyi P, Domingo P, Hoffmann C, Read TR, Pujari S, Meulbroek M, Johnson M, Wilkin T, Mitsuyasu R, ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 9 8() pii

Abstract
BACKGROUND
 In the START study, immediate combination antiretroviral therapy (cART) reduced cancer risk by 64%. We hypothesized that risk reduction was higher for infection-related cancer and determined by differences in CD4 counts and HIV RNA between the study arms.

METHODS
 Incident malignancies in START were categorized into infection-related and infection-unrelated cancer. We used Cox models to assess factors associated with both cancer categories. We used sequential adjustment for baseline covariates, cancer risk factors and HIV-specific variables to investigate potential mediators of cancer risk reduction with immediate cART.

RESULTS
 There were 14 cancers among persons randomized to immediate cART (6 infection-related and 8 infection-unrelated) and 39 cancers in the deferred arm (23 infection-related and 16 infection-unrelated) (Hazard Ratios; 95% CI; of immediate vs deferred cART initiation were 0.26; 0.11-0.64; for infection-related and 0.49; 0.21-1.15; for infection-unrelated cancer). Independent predictors of infection-related cancer were older age, higher BMI, low-middle income region, HIV RNA and baseline CD8 count. Older age and baseline CD8 count were independent predictors of infection-unrelated cancer. Adjustment for latest HIV RNA level had little impact on the protective effect of immediate cART on infection-related cancer. Adjustment for latest HIV RNA level, but not for CD4 count or cancer risk factors, attenuated the effect of immediate cART on infection-unrelated cancer.

CONCLUSIONS
 Immediate cART initiation significantly reduces risk of cancer. Though limited by small sample size, this benefit doesn’t appear to be solely attributable to HIV RNA suppression and may be also mediated by other mechanisms.

Submit a Comment

Your email address will not be published. Required fields are marked *

twelve − seven =

[ HIDE/SHOW ]